Extract

A study comparing the safety and efficacy of adalimumab compared with placebo in patients with active uveitis.

Inclusion criteria

• Uveitis

Country

• Argentina
• Australia
• Austria
• Belgium
• Canada
• Czech Republic
• Denmark
• France
• Germany
• Greece
• Israel
• Italy
• Japan
• Mexico
• Poland
• Portugal
• Spain
• Switzerland
• United Kingdom
• United States

Links

• nct
• ictrp